Global Non-invasive DNA Prenatal Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Non-invasive DNA Prenatal Testing market size was valued at USD 4839.2 million in 2022 and is forecast to a readjusted size of USD 10360 million by 2029 with a CAGR of 11.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.
This report is a detailed and comprehensive analysis for global Non-invasive DNA Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-invasive DNA Prenatal Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-invasive DNA Prenatal Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Non-invasive DNA Prenatal Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Natera, Thermo Fisher Scientific and F. Hoffman-La Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-invasive DNA Prenatal Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Non-invasive DNA Prenatal Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-invasive DNA Prenatal Testing, with revenue, gross margin and global market share of Non-invasive DNA Prenatal Testing from 2018 to 2023.
Chapter 3, the Non-invasive DNA Prenatal Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-invasive DNA Prenatal Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive DNA Prenatal Testing.
Chapter 13, to describe Non-invasive DNA Prenatal Testing research findings and conclusion.
Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.
This report is a detailed and comprehensive analysis for global Non-invasive DNA Prenatal Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-invasive DNA Prenatal Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-invasive DNA Prenatal Testing market shares of main players, in revenue ($ Million), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-invasive DNA Prenatal Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Non-invasive DNA Prenatal Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Natera, Thermo Fisher Scientific and F. Hoffman-La Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-invasive DNA Prenatal Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Equipment
- Consumables
- Hospital
- Clinic
- Other
- Illumina
- Roche
- Natera
- Thermo Fisher Scientific
- F. Hoffman-La Roche
- Pacific Biosciences Of California
- Perkinelmer
- LifeCodexx
- Agilent Technologies
- Labcorp
- Mutiplicon
- Premaitha Health
- Beijing BGI
- Berry Genomics
- Darui Biological
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Non-invasive DNA Prenatal Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-invasive DNA Prenatal Testing, with revenue, gross margin and global market share of Non-invasive DNA Prenatal Testing from 2018 to 2023.
Chapter 3, the Non-invasive DNA Prenatal Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-invasive DNA Prenatal Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-invasive DNA Prenatal Testing.
Chapter 13, to describe Non-invasive DNA Prenatal Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Non-invasive DNA Prenatal Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-invasive DNA Prenatal Testing by Type
1.3.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type in 2022
1.3.3 Equipment
1.3.4 Consumables
1.4 Global Non-invasive DNA Prenatal Testing Market by Application
1.4.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-invasive DNA Prenatal Testing Market Size & Forecast
1.6 Global Non-invasive DNA Prenatal Testing Market Size and Forecast by Region
1.6.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-invasive DNA Prenatal Testing Market Size by Region, (2018-2029)
1.6.3 North America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.6 South America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Non-invasive DNA Prenatal Testing Product and Solutions
2.1.4 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-invasive DNA Prenatal Testing Product and Solutions
2.2.4 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Non-invasive DNA Prenatal Testing Product and Solutions
2.3.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Natera Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 F. Hoffman-La Roche
2.5.1 F. Hoffman-La Roche Details
2.5.2 F. Hoffman-La Roche Major Business
2.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Solutions
2.5.4 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business
2.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Solutions
2.6.4 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pacific Biosciences Of California Recent Developments and Future Plans
2.7 Perkinelmer
2.7.1 Perkinelmer Details
2.7.2 Perkinelmer Major Business
2.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Product and Solutions
2.7.4 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Perkinelmer Recent Developments and Future Plans
2.8 LifeCodexx
2.8.1 LifeCodexx Details
2.8.2 LifeCodexx Major Business
2.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Product and Solutions
2.8.4 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LifeCodexx Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Product and Solutions
2.9.4 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Labcorp
2.10.1 Labcorp Details
2.10.2 Labcorp Major Business
2.10.3 Labcorp Non-invasive DNA Prenatal Testing Product and Solutions
2.10.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Labcorp Recent Developments and Future Plans
2.11 Mutiplicon
2.11.1 Mutiplicon Details
2.11.2 Mutiplicon Major Business
2.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Product and Solutions
2.11.4 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mutiplicon Recent Developments and Future Plans
2.12 Premaitha Health
2.12.1 Premaitha Health Details
2.12.2 Premaitha Health Major Business
2.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Product and Solutions
2.12.4 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Premaitha Health Recent Developments and Future Plans
2.13 Beijing BGI
2.13.1 Beijing BGI Details
2.13.2 Beijing BGI Major Business
2.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Product and Solutions
2.13.4 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing BGI Recent Developments and Future Plans
2.14 Berry Genomics
2.14.1 Berry Genomics Details
2.14.2 Berry Genomics Major Business
2.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Solutions
2.14.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Berry Genomics Recent Developments and Future Plans
2.15 Darui Biological
2.15.1 Darui Biological Details
2.15.2 Darui Biological Major Business
2.15.3 Darui Biological Non-invasive DNA Prenatal Testing Product and Solutions
2.15.4 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Darui Biological Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-invasive DNA Prenatal Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-invasive DNA Prenatal Testing by Company Revenue
3.2.2 Top 3 Non-invasive DNA Prenatal Testing Players Market Share in 2022
3.2.3 Top 6 Non-invasive DNA Prenatal Testing Players Market Share in 2022
3.3 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
3.3.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
3.3.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
3.3.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-invasive DNA Prenatal Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
6.2 North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country
6.3.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
6.3.2 United States Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
7.2 Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country
7.3.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.3 France Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region
8.3.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2029)
8.3.2 China Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.5 India Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
9.2 South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
9.3 South America Non-invasive DNA Prenatal Testing Market Size by Country
9.3.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country
10.3.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-invasive DNA Prenatal Testing Market Drivers
11.2 Non-invasive DNA Prenatal Testing Market Restraints
11.3 Non-invasive DNA Prenatal Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-invasive DNA Prenatal Testing Industry Chain
12.2 Non-invasive DNA Prenatal Testing Upstream Analysis
12.3 Non-invasive DNA Prenatal Testing Midstream Analysis
12.4 Non-invasive DNA Prenatal Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Non-invasive DNA Prenatal Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-invasive DNA Prenatal Testing by Type
1.3.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type in 2022
1.3.3 Equipment
1.3.4 Consumables
1.4 Global Non-invasive DNA Prenatal Testing Market by Application
1.4.1 Overview: Global Non-invasive DNA Prenatal Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Non-invasive DNA Prenatal Testing Market Size & Forecast
1.6 Global Non-invasive DNA Prenatal Testing Market Size and Forecast by Region
1.6.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-invasive DNA Prenatal Testing Market Size by Region, (2018-2029)
1.6.3 North America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.6 South America Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-invasive DNA Prenatal Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Non-invasive DNA Prenatal Testing Product and Solutions
2.1.4 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Non-invasive DNA Prenatal Testing Product and Solutions
2.2.4 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Natera
2.3.1 Natera Details
2.3.2 Natera Major Business
2.3.3 Natera Non-invasive DNA Prenatal Testing Product and Solutions
2.3.4 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Natera Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 F. Hoffman-La Roche
2.5.1 F. Hoffman-La Roche Details
2.5.2 F. Hoffman-La Roche Major Business
2.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Solutions
2.5.4 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 F. Hoffman-La Roche Recent Developments and Future Plans
2.6 Pacific Biosciences Of California
2.6.1 Pacific Biosciences Of California Details
2.6.2 Pacific Biosciences Of California Major Business
2.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Solutions
2.6.4 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pacific Biosciences Of California Recent Developments and Future Plans
2.7 Perkinelmer
2.7.1 Perkinelmer Details
2.7.2 Perkinelmer Major Business
2.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Product and Solutions
2.7.4 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Perkinelmer Recent Developments and Future Plans
2.8 LifeCodexx
2.8.1 LifeCodexx Details
2.8.2 LifeCodexx Major Business
2.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Product and Solutions
2.8.4 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LifeCodexx Recent Developments and Future Plans
2.9 Agilent Technologies
2.9.1 Agilent Technologies Details
2.9.2 Agilent Technologies Major Business
2.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Product and Solutions
2.9.4 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Agilent Technologies Recent Developments and Future Plans
2.10 Labcorp
2.10.1 Labcorp Details
2.10.2 Labcorp Major Business
2.10.3 Labcorp Non-invasive DNA Prenatal Testing Product and Solutions
2.10.4 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Labcorp Recent Developments and Future Plans
2.11 Mutiplicon
2.11.1 Mutiplicon Details
2.11.2 Mutiplicon Major Business
2.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Product and Solutions
2.11.4 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Mutiplicon Recent Developments and Future Plans
2.12 Premaitha Health
2.12.1 Premaitha Health Details
2.12.2 Premaitha Health Major Business
2.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Product and Solutions
2.12.4 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Premaitha Health Recent Developments and Future Plans
2.13 Beijing BGI
2.13.1 Beijing BGI Details
2.13.2 Beijing BGI Major Business
2.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Product and Solutions
2.13.4 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Beijing BGI Recent Developments and Future Plans
2.14 Berry Genomics
2.14.1 Berry Genomics Details
2.14.2 Berry Genomics Major Business
2.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Product and Solutions
2.14.4 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Berry Genomics Recent Developments and Future Plans
2.15 Darui Biological
2.15.1 Darui Biological Details
2.15.2 Darui Biological Major Business
2.15.3 Darui Biological Non-invasive DNA Prenatal Testing Product and Solutions
2.15.4 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Darui Biological Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Non-invasive DNA Prenatal Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-invasive DNA Prenatal Testing by Company Revenue
3.2.2 Top 3 Non-invasive DNA Prenatal Testing Players Market Share in 2022
3.2.3 Top 6 Non-invasive DNA Prenatal Testing Players Market Share in 2022
3.3 Non-invasive DNA Prenatal Testing Market: Overall Company Footprint Analysis
3.3.1 Non-invasive DNA Prenatal Testing Market: Region Footprint
3.3.2 Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
3.3.3 Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Non-invasive DNA Prenatal Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-invasive DNA Prenatal Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
6.2 North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country
6.3.1 North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
6.3.2 United States Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
7.2 Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country
7.3.1 Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.3 France Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region
8.3.1 Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2029)
8.3.2 China Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.5 India Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
9.2 South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
9.3 South America Non-invasive DNA Prenatal Testing Market Size by Country
9.3.1 South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country
10.3.1 Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Non-invasive DNA Prenatal Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Non-invasive DNA Prenatal Testing Market Drivers
11.2 Non-invasive DNA Prenatal Testing Market Restraints
11.3 Non-invasive DNA Prenatal Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Non-invasive DNA Prenatal Testing Industry Chain
12.2 Non-invasive DNA Prenatal Testing Upstream Analysis
12.3 Non-invasive DNA Prenatal Testing Midstream Analysis
12.4 Non-invasive DNA Prenatal Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-invasive DNA Prenatal Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-invasive DNA Prenatal Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Non-invasive DNA Prenatal Testing Product and Solutions
Table 8. Illumina Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Illumina Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Non-invasive DNA Prenatal Testing Product and Solutions
Table 13. Roche Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Natera Company Information, Head Office, and Major Competitors
Table 16. Natera Major Business
Table 17. Natera Non-invasive DNA Prenatal Testing Product and Solutions
Table 18. Natera Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Natera Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Solutions
Table 23. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. F. Hoffman-La Roche Company Information, Head Office, and Major Competitors
Table 26. F. Hoffman-La Roche Major Business
Table 27. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Solutions
Table 28. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. F. Hoffman-La Roche Recent Developments and Future Plans
Table 30. Pacific Biosciences Of California Company Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences Of California Major Business
Table 32. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Solutions
Table 33. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pacific Biosciences Of California Recent Developments and Future Plans
Table 35. Perkinelmer Company Information, Head Office, and Major Competitors
Table 36. Perkinelmer Major Business
Table 37. Perkinelmer Non-invasive DNA Prenatal Testing Product and Solutions
Table 38. Perkinelmer Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Perkinelmer Recent Developments and Future Plans
Table 40. LifeCodexx Company Information, Head Office, and Major Competitors
Table 41. LifeCodexx Major Business
Table 42. LifeCodexx Non-invasive DNA Prenatal Testing Product and Solutions
Table 43. LifeCodexx Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. LifeCodexx Recent Developments and Future Plans
Table 45. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies Major Business
Table 47. Agilent Technologies Non-invasive DNA Prenatal Testing Product and Solutions
Table 48. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies Recent Developments and Future Plans
Table 50. Labcorp Company Information, Head Office, and Major Competitors
Table 51. Labcorp Major Business
Table 52. Labcorp Non-invasive DNA Prenatal Testing Product and Solutions
Table 53. Labcorp Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Labcorp Recent Developments and Future Plans
Table 55. Mutiplicon Company Information, Head Office, and Major Competitors
Table 56. Mutiplicon Major Business
Table 57. Mutiplicon Non-invasive DNA Prenatal Testing Product and Solutions
Table 58. Mutiplicon Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Mutiplicon Recent Developments and Future Plans
Table 60. Premaitha Health Company Information, Head Office, and Major Competitors
Table 61. Premaitha Health Major Business
Table 62. Premaitha Health Non-invasive DNA Prenatal Testing Product and Solutions
Table 63. Premaitha Health Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Premaitha Health Recent Developments and Future Plans
Table 65. Beijing BGI Company Information, Head Office, and Major Competitors
Table 66. Beijing BGI Major Business
Table 67. Beijing BGI Non-invasive DNA Prenatal Testing Product and Solutions
Table 68. Beijing BGI Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Beijing BGI Recent Developments and Future Plans
Table 70. Berry Genomics Company Information, Head Office, and Major Competitors
Table 71. Berry Genomics Major Business
Table 72. Berry Genomics Non-invasive DNA Prenatal Testing Product and Solutions
Table 73. Berry Genomics Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Berry Genomics Recent Developments and Future Plans
Table 75. Darui Biological Company Information, Head Office, and Major Competitors
Table 76. Darui Biological Major Business
Table 77. Darui Biological Non-invasive DNA Prenatal Testing Product and Solutions
Table 78. Darui Biological Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Darui Biological Recent Developments and Future Plans
Table 80. Global Non-invasive DNA Prenatal Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Non-invasive DNA Prenatal Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Non-invasive DNA Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Non-invasive DNA Prenatal Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Non-invasive DNA Prenatal Testing Players
Table 85. Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
Table 86. Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
Table 87. Non-invasive DNA Prenatal Testing New Market Entrants and Barriers to Market Entry
Table 88. Non-invasive DNA Prenatal Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Non-invasive DNA Prenatal Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Non-invasive DNA Prenatal Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023)
Table 93. Global Non-invasive DNA Prenatal Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Non-invasive DNA Prenatal Testing Raw Material
Table 125. Key Suppliers of Non-invasive DNA Prenatal Testing Raw Materials
Table 1. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-invasive DNA Prenatal Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-invasive DNA Prenatal Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Illumina Company Information, Head Office, and Major Competitors
Table 6. Illumina Major Business
Table 7. Illumina Non-invasive DNA Prenatal Testing Product and Solutions
Table 8. Illumina Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Illumina Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Non-invasive DNA Prenatal Testing Product and Solutions
Table 13. Roche Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Natera Company Information, Head Office, and Major Competitors
Table 16. Natera Major Business
Table 17. Natera Non-invasive DNA Prenatal Testing Product and Solutions
Table 18. Natera Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Natera Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Major Business
Table 22. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product and Solutions
Table 23. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Recent Developments and Future Plans
Table 25. F. Hoffman-La Roche Company Information, Head Office, and Major Competitors
Table 26. F. Hoffman-La Roche Major Business
Table 27. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product and Solutions
Table 28. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. F. Hoffman-La Roche Recent Developments and Future Plans
Table 30. Pacific Biosciences Of California Company Information, Head Office, and Major Competitors
Table 31. Pacific Biosciences Of California Major Business
Table 32. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product and Solutions
Table 33. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pacific Biosciences Of California Recent Developments and Future Plans
Table 35. Perkinelmer Company Information, Head Office, and Major Competitors
Table 36. Perkinelmer Major Business
Table 37. Perkinelmer Non-invasive DNA Prenatal Testing Product and Solutions
Table 38. Perkinelmer Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Perkinelmer Recent Developments and Future Plans
Table 40. LifeCodexx Company Information, Head Office, and Major Competitors
Table 41. LifeCodexx Major Business
Table 42. LifeCodexx Non-invasive DNA Prenatal Testing Product and Solutions
Table 43. LifeCodexx Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. LifeCodexx Recent Developments and Future Plans
Table 45. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 46. Agilent Technologies Major Business
Table 47. Agilent Technologies Non-invasive DNA Prenatal Testing Product and Solutions
Table 48. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Agilent Technologies Recent Developments and Future Plans
Table 50. Labcorp Company Information, Head Office, and Major Competitors
Table 51. Labcorp Major Business
Table 52. Labcorp Non-invasive DNA Prenatal Testing Product and Solutions
Table 53. Labcorp Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Labcorp Recent Developments and Future Plans
Table 55. Mutiplicon Company Information, Head Office, and Major Competitors
Table 56. Mutiplicon Major Business
Table 57. Mutiplicon Non-invasive DNA Prenatal Testing Product and Solutions
Table 58. Mutiplicon Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Mutiplicon Recent Developments and Future Plans
Table 60. Premaitha Health Company Information, Head Office, and Major Competitors
Table 61. Premaitha Health Major Business
Table 62. Premaitha Health Non-invasive DNA Prenatal Testing Product and Solutions
Table 63. Premaitha Health Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Premaitha Health Recent Developments and Future Plans
Table 65. Beijing BGI Company Information, Head Office, and Major Competitors
Table 66. Beijing BGI Major Business
Table 67. Beijing BGI Non-invasive DNA Prenatal Testing Product and Solutions
Table 68. Beijing BGI Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Beijing BGI Recent Developments and Future Plans
Table 70. Berry Genomics Company Information, Head Office, and Major Competitors
Table 71. Berry Genomics Major Business
Table 72. Berry Genomics Non-invasive DNA Prenatal Testing Product and Solutions
Table 73. Berry Genomics Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Berry Genomics Recent Developments and Future Plans
Table 75. Darui Biological Company Information, Head Office, and Major Competitors
Table 76. Darui Biological Major Business
Table 77. Darui Biological Non-invasive DNA Prenatal Testing Product and Solutions
Table 78. Darui Biological Non-invasive DNA Prenatal Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Darui Biological Recent Developments and Future Plans
Table 80. Global Non-invasive DNA Prenatal Testing Revenue (USD Million) by Players (2018-2023)
Table 81. Global Non-invasive DNA Prenatal Testing Revenue Share by Players (2018-2023)
Table 82. Breakdown of Non-invasive DNA Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Non-invasive DNA Prenatal Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Non-invasive DNA Prenatal Testing Players
Table 85. Non-invasive DNA Prenatal Testing Market: Company Product Type Footprint
Table 86. Non-invasive DNA Prenatal Testing Market: Company Product Application Footprint
Table 87. Non-invasive DNA Prenatal Testing New Market Entrants and Barriers to Market Entry
Table 88. Non-invasive DNA Prenatal Testing Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Non-invasive DNA Prenatal Testing Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Type (2018-2023)
Table 91. Global Non-invasive DNA Prenatal Testing Consumption Value Forecast by Type (2024-2029)
Table 92. Global Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023)
Table 93. Global Non-invasive DNA Prenatal Testing Consumption Value Forecast by Application (2024-2029)
Table 94. North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Non-invasive DNA Prenatal Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Non-invasive DNA Prenatal Testing Raw Material
Table 125. Key Suppliers of Non-invasive DNA Prenatal Testing Raw Materials
LIST OF FIGURES
Figure 1. Non-invasive DNA Prenatal Testing Picture
Figure 2. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type in 2022
Figure 4. Equipment
Figure 5. Consumables
Figure 6. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Non-invasive DNA Prenatal Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-invasive DNA Prenatal Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Non-invasive DNA Prenatal Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Non-invasive DNA Prenatal Testing Revenue Share by Players in 2022
Figure 22. Non-invasive DNA Prenatal Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Non-invasive DNA Prenatal Testing Market Share in 2022
Figure 24. Global Top 6 Players Non-invasive DNA Prenatal Testing Market Share in 2022
Figure 25. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Non-invasive DNA Prenatal Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Non-invasive DNA Prenatal Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Non-invasive DNA Prenatal Testing Market Drivers
Figure 64. Non-invasive DNA Prenatal Testing Market Restraints
Figure 65. Non-invasive DNA Prenatal Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-invasive DNA Prenatal Testing in 2022
Figure 68. Manufacturing Process Analysis of Non-invasive DNA Prenatal Testing
Figure 69. Non-invasive DNA Prenatal Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Non-invasive DNA Prenatal Testing Picture
Figure 2. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type in 2022
Figure 4. Equipment
Figure 5. Consumables
Figure 6. Global Non-invasive DNA Prenatal Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application in 2022
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Non-invasive DNA Prenatal Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Non-invasive DNA Prenatal Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Non-invasive DNA Prenatal Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Non-invasive DNA Prenatal Testing Revenue Share by Players in 2022
Figure 22. Non-invasive DNA Prenatal Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Non-invasive DNA Prenatal Testing Market Share in 2022
Figure 24. Global Top 6 Players Non-invasive DNA Prenatal Testing Market Share in 2022
Figure 25. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Non-invasive DNA Prenatal Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Non-invasive DNA Prenatal Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Non-invasive DNA Prenatal Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Non-invasive DNA Prenatal Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Non-invasive DNA Prenatal Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Non-invasive DNA Prenatal Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Non-invasive DNA Prenatal Testing Market Drivers
Figure 64. Non-invasive DNA Prenatal Testing Market Restraints
Figure 65. Non-invasive DNA Prenatal Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Non-invasive DNA Prenatal Testing in 2022
Figure 68. Manufacturing Process Analysis of Non-invasive DNA Prenatal Testing
Figure 69. Non-invasive DNA Prenatal Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
